Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea

被引:52
作者
Saarelainen, S
Hasan, J
Siitonen, S
Seppala, E
机构
[1] TAMPERE UNIV HOSP, DEPT CLIN NEUROPHYSIOL, FIN-36280 PIKONLINNA, FINLAND
[2] TAMPERE UNIV HOSP, DEPT CLIN PATHOL, FIN-36280 PIKONLINNA, FINLAND
[3] TAMPERE UNIV HOSP, DEPT CLIN CHEM, FIN-36280 PIKONLINNA, FINLAND
[4] TAMPERE UNIV, FIN-33101 TAMPERE, FINLAND
关键词
aldosterone; blood pressure; nasal continuous airway pressure; obstructive sleep apnoea; plasma volume;
D O I
10.1046/j.1365-2869.1996.t01-1-00007.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Polycythaemia, peripheral oedema formation and hypertension have classically been described in association with obstructive sleep apnoea (OSA). However, there is very limited information about blood volume in OSA and how it changes during longterm treatment with nasal continuous positive airway pressure (nCPAP). Plasma (PV) and red-cell volumes (RCV), 24-h ambulatory blood pressure (BP), 24-h natriuresis and morning plasma aldosterone, renin activity and atrial natriuretic peptide in 11 men with a mean age of 47 y (range 37-55), apnoea index (Al) of 55 (22-106), body mass index of 36 (30-43) and seated BP of greater than or equal to 140/90 mmHg without any medication were measured. BP-measurements were repeated after 3 weeks and all measurements after 3 mo of nCPAP treatment. Aldosterone and 24-h mean heart rates decreased during treatment. Twenty-four-h BP decreased after 3 weeks but that-decrease did not persist after 3 mo of treatment. There was a relationship between changes in night-time mean BP and PV and aldosterone. The haematocrit declined in every patient. No significant changes were found in the mean PV or RCV. They were in all instances lower than has earlier been described for normal, non-obese subjects. These data also suggest that OSA causes divergent individual disturbances in blood volume homeostasis which can be corrected by nCPAP.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 21 条
[1]   THE HYPERSOMNIA SLEEP-APNEA SYNDROME - ITS RECOGNITION IN CLINICAL CARDIOLOGY [J].
BURACK, B .
AMERICAN HEART JOURNAL, 1984, 107 (03) :543-548
[2]   BLOOD VOLUME AND AGE - REPEATED MEASUREMENTS ON NORMAL MEN AFTER 17 YEARS [J].
CHIEN, S ;
USAMI, S ;
SIMMONS, RL ;
GREGERSEN, MI ;
MCALLISTER, FF .
JOURNAL OF APPLIED PHYSIOLOGY, 1966, 21 (02) :583-+
[3]   AMBULATORY BLOOD-PRESSURE AND LEFT-VENTRICULAR HYPERTROPHY IN SUBJECTS WITH UNTREATED OBSTRUCTIVE SLEEP-APNEA AND SNORING, COMPARED WITH MATCHED CONTROL SUBJECTS, AND THEIR RESPONSE TO TREATMENT [J].
DAVIES, RJO ;
CROSBY, J ;
PROTHERO, A ;
STRADLING, JR .
CLINICAL SCIENCE, 1994, 86 (04) :417-424
[4]  
Ehlenz K, 1991, Pneumologie, V45 Suppl 1, P239
[5]  
FOLLENIUS M, 1991, SLEEP, V14, P211
[6]  
GROTE L, 1995, EUR RESPIR J, V19, P987
[7]   REDUCTION IN SYMPATHETIC ACTIVITY AFTER LONG-TERM CPAP TREATMENT IN SLEEP-APNEA - CARDIOVASCULAR IMPLICATIONS [J].
HEDNER, J ;
DARPO, B ;
EJNELL, H ;
CARLSON, J ;
CAIDAHL, K .
EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (02) :222-229
[8]  
*INT COMM STAND HA, 1980, J NUCL MED, V231, P793
[9]   BLOOD-PRESSURE, CATECHOLAMINES, AND PANCREATIC-POLYPEPTIDE IN OBSTRUCTIVE SLEEP-APNEA WITH AND WITHOUT NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE (NCPAP) TREATMENT [J].
JENNUM, P ;
WILDSCHIODTZ, G ;
CHRISTENSEN, NJ ;
SCHWARTZ, T .
AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (11) :847-852
[10]  
KRIEGER J, 1992, EUR RESPIR J, V5, P228